Clinical trial

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol…

NCT00146471 · Charite University, Berlin, Germany, Other · Completed

Key facts

NCT number NCT00146471
Title Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
Official title Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms]
Lead sponsor Charite University, Berlin, Germany, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Alcohol Withdrawal Syndrome
Intervention type Drug
Interventions Levetiracetam, Placebo
Enrollment 120
Start date Jan 1, 2006
Primary completion Jul 1, 2007
Completion Sep 1, 2007
First posted Sep 7, 2005
Last update posted Dec 30, 2009
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies